Summary of Owlet (OWLT) Q4 2025 Earnings Call

1Key Financial Results and Metrics

Q4 2025 Revenue: $26.6 million, up 29.6% year-over-year.

Full Year 2025 Revenue: $105.7 million, a 35.4% increase from 2024.

Q4 Gross Margin: 47.6%, impacted by tariffs (510 basis points).

Full Year 2025 Gross Margin: Record high of 50.6%.

Q4 Adjusted EBITDA: $0.1 million, down from $0.5 million in Q4 2024.

Full Year 2025 Adjusted EBITDA: $2 million, a $3.8 million improvement over 2024.

Cash Position: $35.5 million as of December 31, 2025, up from $23.8 million in Q3 2025.

2Strategic Updates and Business Highlights

Owlet360 Subscription Service: Launched in January 2025, now has over 110,000 paying subscribers, contributing to long-term customer relationships.

Product Launches: Introduced the Dream Sight camera in September 2025, enhancing the product suite and expected to drive further subscription growth.

International Expansion: Q4 international revenue reached $3.9 million, with significant growth in markets like the U.K. and France. Regulatory approvals in India and Israel are set to enhance future sales channels.

Healthcare Partnerships: Expanded Medicaid coverage to 37 states and increased commercial insurance partnerships to 258, covering over 90% of U.S. births.

Telehealth Initiative: Owlet OnCall platform expected to launch in the second half of 2026, leveraging real-time data from existing products to enhance pediatric care.

3Forward Guidance and Outlook

Q1 2026 Revenue Guidance: Expected between $20 million and $21 million, reflecting seasonality and a softer consumer spending environment.

Full Year 2026 Revenue Guidance: Projected between $126 million and $130 million, representing 19% to 23% growth over 2025.

Adjusted EBITDA for 2026: Expected between $3 million and $5 million, indicating a significant improvement over 2025.

Gross Margin Expectations: Anticipated between 49% and 52% for the full year 2026, factoring in ongoing tariff impacts.

4Bad News, Challenges, or Points of Concern

Tariff Impact: Tariffs continue to affect gross margins, with an estimated 510 basis point impact expected to persist.

Consumer Spending Softness: Noted a decline in consumer spending during Q4 2025, which may affect Q1 2026 performance.

International Revenue Transition: A shift to a direct import model in the U.K. has delayed revenue recognition, pushing some sales into Q1 2026.

FDA Communication: No new updates from the FDA regarding safety communications, although the company maintains a strong market position.

5Notable Q&A Insights

Q1 Revenue Guidance: Management acknowledged that Q1 is typically the weakest quarter due to seasonality and the impact of a strong prior year driven by health crises.

AI Integration: Plans to leverage AI for personalized health insights and enhance the Owlet360 subscription, aiming to evolve from a hardware-centric to a data-driven platform.

International Market Potential: Significant growth opportunities identified in international markets, particularly in India and Europe, with plans to expand subscription services.

Telehealth Strategy: Owlet OnCall will be positioned as a premium add-on to the existing subscription, with a focus on enhancing care quality through real-time data sharing. Overall, Owlet reported a strong performance in 2025, with strategic initiatives set to drive future growth, although challenges related to tariffs and consumer spending remain.